
Opinion|Videos|July 10, 2024
Improvement in Management of Duchenne Muscular Dystrophy in Recent Years
Author(s)Emma Ciafaloni, MD
A neurologist discusses how recent approvals of therapies for Duchenne muscular dystrophy have improved patient outcomes.
Advertisement
Episodes in this series

Video content above is prompted by the following questions:
- How have these recent approvals improved the management of Duchenne muscular dystrophy (DMD)?
- Share your experience with recent approvals in DMD.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Tolebrutinib Falls Short in Phase 3 PERSEUS Study, Forcing Decision to Redact Regulatory Submission
2
Understanding the Therapeutic Potential and Promising Early-Stage Data on Azetukalner for Focal Onset Seizures
3
How Social Robotics and Embodied AI Could Reshape Neurology Care
4
Early Data of Neflamapimod Showing Potential Benefit in Dementia With Lewy Bodies: John-Paul Taylor, MBBS, PhD, MRCPsych
5
































